BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moor CC, Gür-Demirel Y, Wijsenbeek MS. Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis. J Pers Med 2019;9:E23. [PMID: 31060343 DOI: 10.3390/jpm9020023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Wijsenbeek MS, Moor CC, Johannson KA, Jackson PD, Khor YH, Kondoh Y, Rajan SK, Tabaj GC, Varela BE, van der Wal P, van Zyl-smit RN, Kreuter M, Maher TM. Home monitoring in interstitial lung diseases. The Lancet Respiratory Medicine 2022. [DOI: 10.1016/s2213-2600(22)00228-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Nakshbandi G, Moor CC, Nossent EJ, Geelhoed JJM, Baart SJ, Boerrigter BG, Aerts JGJV, Nijman SFM, Santema HY, Hellemons ME, Wijsenbeek MS. Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN' study. Respirology 2022. [PMID: 35441433 DOI: 10.1111/resp.14262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Althobiani M, Alqahtani JS, Hurst JR, Russell AM, Porter J. Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians. BMJ Open Respir Res 2021;8:e001088. [PMID: 34969772 DOI: 10.1136/bmjresp-2021-001088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cerdan de Las Heras J, Balbino F, Catalán-Matamoros D, Løkke A, Hilberg O, Bendstrup E. Effect of a Telerehabilitation program in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2022;39:e2022003. [PMID: 35494172 DOI: 10.36141/svdld.v39i1.12526] [Reference Citation Analysis]
5 Althobiani MA, Evans RA, Alqahtani JS, Aldhahir AM, Russell AM, Hurst JR, Porter JC. Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review. ERJ Open Res 2021;7:00441-2021. [PMID: 34938799 DOI: 10.1183/23120541.00441-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kahlmann V, Manansala M, Moor CC, Shahrara S, Wijsenbeek MS, Sweiss NJ. COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes. Curr Opin Pulm Med 2021;27:463-71. [PMID: 34397613 DOI: 10.1097/MCP.0000000000000812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Moor CC, van Leuven SI, Wijsenbeek MS, Vonk MC. Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study. Rheumatology (Oxford) 2021;60:2467-71. [PMID: 33212511 DOI: 10.1093/rheumatology/keaa607] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
8 Herrera-Olivares AM, García-Manso JM, Rodríguez-Gómez I, Ara I, Lucia A, Santalla A. Long-Term Benefits of Tailored Exercise in Severe Sarcoidosis: A Case Report. Int J Environ Res Public Health 2020;17:E9512. [PMID: 33353138 DOI: 10.3390/ijerph17249512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wijbenga N, Hoek RAS, Mathot BJ, Seghers L, van Weezel JJ, den Ouden J, Wijsenbeek MS, Aerts JGJV, Hellemons ME, Moor CC. Evaluation of a Home Monitoring Application for Follow Up after Lung Transplantation-A Pilot Study. J Pers Med 2020;10:E240. [PMID: 33233334 DOI: 10.3390/jpm10040240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Veit T, Barnikel M, Crispin A, Kneidinger N, Ceelen F, Arnold P, Munker D, Schmitzer M, Barton J, Schiopu S, Schiller HB, Frankenberger M, Milger K, Behr J, Neurohr C, Leuschner G. Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study. Respir Res 2020;21:270. [PMID: 33076914 DOI: 10.1186/s12931-020-01524-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
11 Kahlmann V, Janssen Bonás M, Moor CC, van Moorsel CHM, Kool M, Kraaijvanger R, Grutters JC, Overgaauw M, Veltkamp M, Wijsenbeek MS; Collaborating investigators. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study. BMC Pulm Med 2020;20:271. [PMID: 33076885 DOI: 10.1186/s12890-020-01290-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
12 Drent M, Elfferich M, Breedveld E, Vries J, Strookappe B. Benefit of Wearing an Activity Tracker in Sarcoidosis. J Pers Med 2020;10:E97. [PMID: 32842583 DOI: 10.3390/jpm10030097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
13 Harrison T, Pavord ID, Chalmers JD, Whelan G, Fagerås M, Rutgersson A, Belton L, Siddiqui S, Gustafson P. Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design. ERJ Open Res 2020;6:00333-2019. [PMID: 32550224 DOI: 10.1183/23120541.00333-2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive Care for Patients with Sarcoidosis. J Clin Med 2020;9:E390. [PMID: 32024123 DOI: 10.3390/jcm9020390] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
15 Drent M, Proesmans VLJ, Elfferich MDP, Jessurun NT, de Jong SMG, Ebner NM, Lewis EDO, Bast A. Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis. Lung 2020;198:395-403. [PMID: 31960165 DOI: 10.1007/s00408-020-00323-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]